EMA Adopts Revised Drug Development Guidelines for Two Inflammatory Diseases

Drug Industry Daily
A A
The European Medicines Agency released new guidelines on developing treatments for Crohn’s disease and ulcerative colitis set to take effect Jan. 1.

To View This Article:

Login

Subscribe To Drug Industry Daily